147 related articles for article (PubMed ID: 14966075)
1. Clopidogrel induced urticarial rash in a patient with left main stem percutaneous coronary intervention: management issues.
Khambekar SK; Kovac J; Gershlick AH
Heart; 2004 Mar; 90(3):e14. PubMed ID: 14966075
[TBL] [Abstract][Full Text] [Related]
2. Rash with both clopidogrel and ticlopidine in two patients following percutaneous coronary intervention with drug-eluting stents.
Makkar K; Wilensky RL; Julien MB; Herrmann HC; Spinler SA
Ann Pharmacother; 2006 Jun; 40(6):1204-7. PubMed ID: 16684808
[TBL] [Abstract][Full Text] [Related]
3. Case report on clopidogrel rash after coronary placement of a paclitaxol-coated stent.
Satish B; Tressa K; Harish CR
Crit Pathw Cardiol; 2007 Mar; 6(1):24-5. PubMed ID: 17667883
[TBL] [Abstract][Full Text] [Related]
4. Clopidogrel desensitization.
Lee-Wong M; Gadhvi D; Resnick D
Ann Allergy Asthma Immunol; 2006 May; 96(5):756-7. PubMed ID: 16729795
[No Abstract] [Full Text] [Related]
5. Subacute coronary stent thrombosis in a patient developing clopidogrel associated thrombotic thrombocytopenic purpura.
von Mach MA; Eich A; Weilemann LS; Münzel T
Heart; 2005 Feb; 91(2):e14. PubMed ID: 15657204
[TBL] [Abstract][Full Text] [Related]
6. Severe neutropenia under clopidogrel treatment three weeks after coronary stenting.
Schäfer A; Eigenthaler M; Bauersachs J
Thromb Haemost; 2007 Feb; 97(2):317-8. PubMed ID: 17264964
[No Abstract] [Full Text] [Related]
7. A paclitaxel-eluting stent for the prevention of coronary restenosis.
Park SJ; Shim WH; Ho DS; Raizner AE; Park SW; Hong MK; Lee CW; Choi D; Jang Y; Lam R; Weissman NJ; Mintz GS
N Engl J Med; 2003 Apr; 348(16):1537-45. PubMed ID: 12700373
[TBL] [Abstract][Full Text] [Related]
8. Clopidogrel and coronary stents: risks and benefits.
Mood GR; Bavry AA; Bhatt DL
Curr Atheroscler Rep; 2008 Aug; 10(4):303-8. PubMed ID: 18606101
[TBL] [Abstract][Full Text] [Related]
9. Evaluating the safety of very short-term (10 days) dual antiplatelet therapy after Genous™ bio-engineered R stent™ implantation: the multicentre pilot Genous trial.
Sangiorgi GM; Morice MC; Bramucci E; Ferlini M; Grinfeld L; Petronio AS; Pierli C; Iadanza A; Biondi-Zoccai G; Colombo A
EuroIntervention; 2011 Nov; 7(7):813-9. PubMed ID: 22082577
[TBL] [Abstract][Full Text] [Related]
10. The effect of long-term clopidogrel use on neointimal formation after percutaneous coronary intervention.
Akbulut M; Ozbay Y; Karaca I; Ilkay E; Gundogdu O; Arslan N
Coron Artery Dis; 2004 Sep; 15(6):347-52. PubMed ID: 15346093
[TBL] [Abstract][Full Text] [Related]
11. Combined aspirin and clopidogrel resistance associated with recurrent coronary stent thrombosis.
Templin C; Schaefer A; Stumme B; Drexler H; von Depka M
Clin Res Cardiol; 2006 Feb; 95(2):122-6. PubMed ID: 16598523
[TBL] [Abstract][Full Text] [Related]
12. Clopidogrel for prevention of major cardiac events after coronary stent implantation: 30-day and 6-month results in patients with smaller stents.
Calver AL; Blows LJ; Harmer S; Dawkins KD; Gray HH; Morgan JH; Simpson IA
Am Heart J; 2000 Sep; 140(3):483-91. PubMed ID: 10966552
[TBL] [Abstract][Full Text] [Related]
13. [Stents in interventional cardiology].
Grinius V; Navickas R; Unikas R
Medicina (Kaunas); 2007; 43(3):183-9. PubMed ID: 17413246
[TBL] [Abstract][Full Text] [Related]
14. Understanding and minimizing late thrombosis of drug-eluting stents.
Rabbat MG; Bavry AA; Bhatt DL; Ellis SG
Cleve Clin J Med; 2007 Feb; 74(2):129-36. PubMed ID: 17333640
[TBL] [Abstract][Full Text] [Related]
15. [Clopidogrel and thrombopenia. A case report].
Helft G; Elalamy I; Laudy C; Tran D; Beygui F; Le Feuvre C; Ounissi F; Monnet de Lorbeau B; Khellaf C; Metzger JP
Ann Cardiol Angeiol (Paris); 2003 Jun; 52(3):191-3. PubMed ID: 12938574
[TBL] [Abstract][Full Text] [Related]
16. Effects of triple antiplatelet therapy (aspirin, clopidogrel, and cilostazol) on platelet aggregation and P-selectin expression in patients undergoing coronary artery stent implantation.
Lee BK; Lee SW; Park SW; Lee SW; Park DW; Kim YH; Lee CW; Hong MK; Kim JJ; Jang S; Chi HS; Park SJ
Am J Cardiol; 2007 Aug; 100(4):610-4. PubMed ID: 17697815
[TBL] [Abstract][Full Text] [Related]
17. Clopidogrel and stent thrombosis after percutaneous coronary intervention.
Gladding P; Webster M
N Z Med J; 2007 Jun; 120(1255):U2554. PubMed ID: 17546102
[No Abstract] [Full Text] [Related]
18. Adjunctive cilostazol versus double-dose clopidogrel after drug-eluting stent implantation: the HOST-ASSURE randomized trial (Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis-Safety & Effectiveness of Drug-Eluting Stents & Anti-platelet Regimen).
Park KW; Kang SH; Park JJ; Yang HM; Kang HJ; Koo BK; Park BE; Cha KS; Rhew JY; Jeon HK; Shin ES; Oh JH; Jeong MH; Kim S; Hwang KK; Yoon JH; Lee SY; Park TH; Moon KW; Kwon HM; Chae IH; Kim HS
JACC Cardiovasc Interv; 2013 Sep; 6(9):932-42. PubMed ID: 24050860
[TBL] [Abstract][Full Text] [Related]
19. Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial.
Wiviott SD; Braunwald E; McCabe CH; Horvath I; Keltai M; Herrman JP; Van de Werf F; Downey WE; Scirica BM; Murphy SA; Antman EM;
Lancet; 2008 Apr; 371(9621):1353-63. PubMed ID: 18377975
[TBL] [Abstract][Full Text] [Related]
20. Clopidogrel is associated with better in-hospital and 30-day outcomes than ticlopidine after coronary stenting.
L'Allier PL; Aronow HD; Cura FA; Bhatt DL; Albirini A; Schneider JP; Topol EJ; Ellis SG
Can J Cardiol; 2003 Aug; 19(9):1041-6. PubMed ID: 12915931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
